FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type mCRC: the subgroup-analysis of DEEPER trial (JACCRO CC-13)
Taichi Yabuno,Akihito Tsuji,Takuya Tokunaga,Satoshi Yuki,Toshihiro Kudo,Naoki Mashita,Koji Ando,Nobumichi Takeuchi,Tomomi Kashiwada,Masato Kataoka,Mitsugu Kochi,Tamotsu Sagawa,Masahito Kotaka,Yutaro Kubota,Yu Sunakawa,Takashi Sekikawa,Masato Nakamura,Masahiro Takeuchi,Wataru Ichikawa,Masashi Fujii ANNALS OF ONCOLOGY（2022）
AI 理解论文
溯源树
样例
